NO20055986L - Forbindelse for behandling og forebygging av virale infeksjonssykdommer - Google Patents
Forbindelse for behandling og forebygging av virale infeksjonssykdommerInfo
- Publication number
- NO20055986L NO20055986L NO20055986A NO20055986A NO20055986L NO 20055986 L NO20055986 L NO 20055986L NO 20055986 A NO20055986 A NO 20055986A NO 20055986 A NO20055986 A NO 20055986A NO 20055986 L NO20055986 L NO 20055986L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- infectious diseases
- viral infectious
- prevention
- same
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000035473 Communicable disease Diseases 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Epoxy Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003272420 | 2003-07-09 | ||
| PCT/JP2004/009803 WO2005005372A1 (ja) | 2003-07-09 | 2004-07-09 | 抗ｈｃｖ作用を有する化合物およびその製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055986L true NO20055986L (no) | 2006-02-13 |
Family
ID=34055974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055986A NO20055986L (no) | 2003-07-09 | 2005-12-16 | Forbindelse for behandling og forebygging av virale infeksjonssykdommer |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7378446B2 (pt) |
| EP (1) | EP1661882B1 (pt) |
| JP (1) | JP4068639B2 (pt) |
| KR (1) | KR20060029182A (pt) |
| CN (1) | CN1819990B (pt) |
| AU (1) | AU2004255633B2 (pt) |
| BR (1) | BRPI0412459A (pt) |
| CA (1) | CA2531790A1 (pt) |
| IL (1) | IL172666A0 (pt) |
| MX (1) | MXPA06000294A (pt) |
| MY (1) | MY143775A (pt) |
| NO (1) | NO20055986L (pt) |
| NZ (1) | NZ545102A (pt) |
| RU (1) | RU2346933C2 (pt) |
| TW (1) | TWI330173B (pt) |
| UA (1) | UA92134C2 (pt) |
| WO (1) | WO2005005372A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006077004A (ja) * | 2004-08-11 | 2006-03-23 | Chugai Pharmaceut Co Ltd | 抗ｈｃｖ作用を有する化合物およびそれを含む医薬組成物 |
| US8183005B1 (en) | 2004-08-11 | 2012-05-22 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical agents for treating HCV infections |
| JPWO2006088071A1 (ja) * | 2005-02-17 | 2008-07-03 | 中外製薬株式会社 | 抗ｈｃｖ作用を有する化合物の製造方法およびその中間体 |
| WO2007000994A1 (ja) * | 2005-06-28 | 2007-01-04 | Chugai Seiyaku Kabushiki Kaisha | 抗ｈｃｖ作用を有する化合物の製造方法 |
| EP1957476A1 (en) * | 2005-11-23 | 2008-08-20 | AstraZeneca AB | L-alanine derivatives |
| JPWO2007132882A1 (ja) | 2006-05-16 | 2009-09-24 | 財団法人 東京都医学研究機構 | Ｈｃｖ感染症を治療または予防するための医薬組成物 |
| JP2009539815A (ja) * | 2006-06-09 | 2009-11-19 | アストラゼネカ アクチボラグ | 固形腫瘍の治療用のａ５ｂ１アンタゴニストとしてのＮ−（ベンゾイル）−Ｏ−［２−（ピリジン−２−イルアミノ）エチル］−Ｌ−チロシン誘導体と関連化合物 |
| US20090062267A1 (en) * | 2007-01-29 | 2009-03-05 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| WO2008125811A1 (en) * | 2007-04-11 | 2008-10-23 | Astrazeneca Ab | N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS |
| TW201010692A (en) | 2008-06-19 | 2010-03-16 | Public Univ Corp Nagoya City Univ | Pharmaceutical composition for treatment or prevention of hbv infection |
| EP2368989A4 (en) | 2008-11-26 | 2012-09-26 | Chugai Pharmaceutical Co Ltd | OLIGORIBONUCLEOTID- BZW. PEPTID NUCLEIC ACID TO INHIBIT THE ACTIVITY OF HEPATITIS C VIRUS |
| JP2013121935A (ja) * | 2011-12-12 | 2013-06-20 | Institute Of Microbial Chemistry | 化合物、及び不斉合成反応 |
| EP2886530A4 (en) | 2012-08-17 | 2016-01-27 | Chugai Pharmaceutical Co Ltd | ORAL ADMINISTRATIVE VIRIDIDEIN DERIVATIVE WITH ANTI-HCV ACTIVITY |
| JP7565930B2 (ja) * | 2019-08-23 | 2024-10-11 | パナソニックホールディングス株式会社 | 支援装置、分析装置、支援方法、分析方法、およびプログラム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364948A (en) * | 1991-08-02 | 1994-11-15 | Merck & Co., Inc. | Biologically active compounds isolated from aerobic fermentation of Trichoderma viride |
| EP0526936A3 (en) | 1991-08-02 | 1993-05-05 | Merck & Co. Inc. | Cholesterol-lowering agents |
| US5503973A (en) | 1992-05-29 | 1996-04-02 | The Regents Of The University Of California | Method for inhibition of viral morphogenesis |
| DE4415312A1 (de) * | 1994-05-02 | 1995-11-09 | Hoechst Ag | Verfahren zur Herstellung von N-Acylglycinderivaten |
| JP4091130B2 (ja) * | 1997-06-09 | 2008-05-28 | タカラバイオ株式会社 | 生理活性物質ｔｋｒ２４４９類、製造方法及び微生物 |
| JP5025051B2 (ja) | 2001-07-26 | 2012-09-12 | サトーホールディングス株式会社 | 印字編集処理装置 |
| JP4093534B2 (ja) | 2002-03-15 | 2008-06-04 | スタンレー電気株式会社 | 車両用前照灯 |
| MY141506A (en) | 2003-02-12 | 2010-05-14 | Chugai Pharmaceutical Co Ltd | Virus therapeutic drug |
-
2004
- 2004-07-09 MX MXPA06000294A patent/MXPA06000294A/es active IP Right Grant
- 2004-07-09 WO PCT/JP2004/009803 patent/WO2005005372A1/ja not_active Ceased
- 2004-07-09 NZ NZ545102A patent/NZ545102A/en not_active IP Right Cessation
- 2004-07-09 RU RU2006103803/04A patent/RU2346933C2/ru not_active IP Right Cessation
- 2004-07-09 US US10/563,089 patent/US7378446B2/en not_active Expired - Fee Related
- 2004-07-09 UA UAA200601259A patent/UA92134C2/ru unknown
- 2004-07-09 JP JP2005511532A patent/JP4068639B2/ja not_active Expired - Fee Related
- 2004-07-09 CA CA002531790A patent/CA2531790A1/en not_active Abandoned
- 2004-07-09 CN CN2004800196454A patent/CN1819990B/zh not_active Expired - Fee Related
- 2004-07-09 MY MYPI20042769A patent/MY143775A/en unknown
- 2004-07-09 BR BRPI0412459-6A patent/BRPI0412459A/pt not_active IP Right Cessation
- 2004-07-09 AU AU2004255633A patent/AU2004255633B2/en not_active Ceased
- 2004-07-09 EP EP04747271.7A patent/EP1661882B1/en not_active Expired - Lifetime
- 2004-07-09 TW TW093120575A patent/TWI330173B/zh not_active IP Right Cessation
- 2004-07-09 KR KR1020067000420A patent/KR20060029182A/ko not_active Ceased
-
2005
- 2005-12-16 NO NO20055986A patent/NO20055986L/no not_active Application Discontinuation
- 2005-12-18 IL IL172666A patent/IL172666A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL172666A0 (en) | 2006-04-10 |
| US20060194870A1 (en) | 2006-08-31 |
| CN1819990B (zh) | 2010-04-21 |
| RU2006103803A (ru) | 2006-08-10 |
| KR20060029182A (ko) | 2006-04-04 |
| EP1661882B1 (en) | 2013-10-30 |
| MXPA06000294A (es) | 2006-04-18 |
| EP1661882A1 (en) | 2006-05-31 |
| WO2005005372A1 (ja) | 2005-01-20 |
| NZ545102A (en) | 2008-11-28 |
| US7378446B2 (en) | 2008-05-27 |
| EP1661882A4 (en) | 2007-01-31 |
| CN1819990A (zh) | 2006-08-16 |
| TWI330173B (en) | 2010-09-11 |
| CA2531790A1 (en) | 2005-01-20 |
| TW200524847A (en) | 2005-08-01 |
| RU2346933C2 (ru) | 2009-02-20 |
| BRPI0412459A (pt) | 2006-10-17 |
| HK1093485A1 (zh) | 2007-03-02 |
| JP4068639B2 (ja) | 2008-03-26 |
| AU2004255633B2 (en) | 2009-08-06 |
| AU2004255633A1 (en) | 2005-01-20 |
| UA92134C2 (ru) | 2010-10-11 |
| JPWO2005005372A1 (ja) | 2006-08-24 |
| MY143775A (en) | 2011-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055986L (no) | Forbindelse for behandling og forebygging av virale infeksjonssykdommer | |
| NO20070751L (no) | Inhibitorer av HCV-replifikasjon | |
| NO20062339L (no) | Hepatitt C virus-inhibitoerer | |
| NO20044807L (no) | Heratitt C virus inhibitorer | |
| WO2003015798A1 (fr) | Nouvelle methode virocide/inhibitrice de la proliferation virale et nouvel analogue de pyradine nucleotide/pyradine nucleoside | |
| NO20070247L (no) | Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase | |
| WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
| HUP0101137A2 (hu) | Véralvadást gátló savamidin-származékok és gyógyászati alkalmazásuk | |
| NO20062267L (no) | Hepatitt C virus inhibitorer | |
| EP2374464A3 (en) | HCV N3S-NS4A protease inhibition | |
| DE602006016313D1 (de) | Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c | |
| WO2007038507A3 (en) | Modified 4'-nucleosides as antiviral agents | |
| MY146669A (en) | Pyrazole derivatives for treating hiv | |
| NO20062185L (no) | Hepatitt C virus-inhibitorer | |
| WO2005084192A3 (en) | Novel 2’-c-methyl nucleoside derivatives | |
| HRP20060254A2 (en) | Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | |
| CY1113038T1 (el) | Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου | |
| NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
| NO20091704L (no) | Inhibitorer av hepatitt C virus | |
| NO20091707L (no) | Inhibitorer av hepatitt C virus | |
| JP2005539088A5 (pt) | ||
| WO2006005609A3 (de) | Substituierte oxindol-derivate und diese enthaltende arzneimittel | |
| EA201270275A1 (ru) | Кристаллическое соединение пиридазина | |
| GEP20094826B (en) | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands | |
| NO983991L (no) | Serin-protease-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |